journal article·2025-10

Mineralized extracellular matrix composite scaffold incorporated with salvianolic acid A enhances bone marrow mesenchymal stem cell osteogenesis and promotes calvarial bone regeneration

Jiayu Chen, Qing Liu, Jiayang Wan, Qihua Cao, Zili Guo, Kaijia Tang, Xin Chen, Qilei Lou, Xiaodong Xu, Yong Fu, Xiaoqiang Jin, Songying Zhang, Xiaohua Yu, Chang Li

Publisher page

Abstract

Natural products, especially phenolic components isolated from Traditional Chinese Medicine (TCM), were reported to exhibit significant osteogenic potential in treating bone defects. However, low bioavailability, short half-life, and high clearance rate in the body hindered their practical applications in many cases. To develop delivery technologies for a bioactive phenolic acid from Salvia miltiorrhiza (Danshen), salvianolic acid A (SAA), a sustained release system based on biocompatible extracellular matrix (ECM) meticulously modified with a Hydroxyapatite (HAP) mineralized coating was established. The SAA construction of such delivery system not only addressed the low bioavailability of TCM formulation for SAA by local sustained release of this molecule, but also remarkably promoted its bone healing outcomes by synergizing with calcium and phosphate ion release during SAA release period. This approach collectively had a synergistic effect of osteogenesis with SAA, thereby significantly enhanced the efficacy of SAA in promoting bone formation. The in vitro experimental results indicated that the SAA@MECM exhibited good biocompatibility and significantly enhances angiogenesis and osteogenic differentiation. By day 14, compared to the MECM group, the gene expression levels of ColI, ALP, Runx-2, and OCN in the SAA-H group increased by 1.8, 1.5, 1.5, and 2.0 times, respectively. This demonstrates the potential role of SAA in promoting the activity and differentiation of osteoblasts, highlighting its potential applications in bone tissue engineering. Leveraging such favorable feature of this system, SAA-loaded MECM demonstrated extraordinary bone healing capability in a rat calvarial defect model by showing successful bridging of the defects and large amount of new bone formation. Histological analysis further confirmed its outstanding osteogenic potential, while the dense distribution of micro vessels in the newly formed bone revealed the scaffold's remarkable potential in enhancing vascularization. This study might offer an innovative delivery strategy for enhancing the efficacy of natural phenolic acids through biomaterials.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Spine and Intervertebral Disc Pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. A multifunctional neuromodulation platform utilizing Schwann cell-derived exosomes orchestrates bone microenvironment via immunomodulation, angiogenesis and osteogenesis
2. Engineered sensory nerve guides self-adaptive bone healing via NGF-TrkA signaling pathway
3. Injectable hydrogel with NIR light-responsive, dual-mode PTH release for osteoregeneration in osteoporosis10.1002/adfm.202105383 ↗
4. Charge-guided micro/nano-hydrogel microsphere for penetrating cartilage matrix
5. Smart-responsive multifunctional therapeutic system for improved regenerative microenvironment and accelerated bone regeneration via mild photothermal therapy
6. In situ imaging and anti-inflammation of 3D printed scaffolds enabled by AIEgen10.1021/acsami.3c03082 ↗
7. Effect of Salvia miltiorrhiza extract on bone formation10.1002/jbm.a.31577 ↗
8. PLGA/β-TCP composite scaffold incorporating salvianolic acid B promotes bone fusion by angiogenesis and osteogenesis in a rat spinal fusion model10.1016/j.biomaterials.2018.04.004 ↗
9. Efficacy of Danshen injection combined with Calcitriol and Calcium/Vitamin-D for the treatment of osteoporotic fractures: a retrospective case-control study
10. Effects of traditional Chinese medicine on bone remodeling during orthodontic tooth movement10.1016/j.jep.2011.09.003 ↗
11. Danshen (Salvia miltiorrhiza) protects ovariectomized rats fed with high-saturated fat-sucrose diet from bone loss10.1007/s00198-017-4254-2 ↗
12. Bone-targeting liposome formulation of Salvianic acid A accelerates the healing of delayed fracture Union in Mice10.1016/j.nano.2018.07.011 ↗
13. Osteogenic effects of D(+)Β-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats10.1038/aps.2009.9 ↗
14. Salvianolic acid A inhibits endothelial dysfunction and vascular remodeling in spontaneously hypertensive rats10.1016/j.lfs.2015.06.010 ↗
15. Expanding the therapeutic potential of Salvia miltiorrhiza: a review of its pharmacological applications in musculoskeletal diseases10.3389/fphar.2023.1276038 ↗
16. Advanced collagen-based biomaterials for regenerative biomedicine10.1002/adfm.201804943 ↗
17. An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss10.1126/scitranslmed.3008085 ↗
18. ADSC-derived exosomes-coupled decellularized matrix for endometrial regeneration and fertility restoration
19. Enhancing the regenerative effectiveness of growth factors by local inhibition of interleukin-1 receptor signaling10.1126/sciadv.aba7602 ↗
20. Vascular derived ECM improves therapeutic index of BMP-2 and drives vascularized bone regeneration
21. Decellularized extracellular matrix biomaterials for regenerative therapies: advances, challenges and clinical prospects
22. Three-dimensional bioprinting biphasic multicellular living scaffold facilitates osteochondral defect regeneration
23. Advances on the modification and biomedical applications of acellular dermal matrices10.1186/s42825-022-00093-4 ↗
24. Spatiotemporal regulation of angiogenesis/osteogenesis emulating natural bone healing cascade for vascularized bone formation10.1186/s12951-021-01173-z ↗
25. Surface functionalization of hydroxyapatite scaffolds with MgAlEu-LDH nanosheets for high-performance bone regeneration
26. Oxygen-carrying and antibacterial fluorinated nano-hydroxyapatite incorporated hydrogels for enhanced bone regeneration10.1002/adhm.202102540 ↗
27. Mussel-inspired immunomodulatory and osteoinductive dual-functional hydroxyapatite nanoplatform for promoting bone regeneration10.1186/s12951-024-02593-3 ↗
28. Simvastatin-hydroxyapatite coatings prevent biofilm formation and improve bone formation in implant-associated infections
29. 3D-printed dual-ion chronological release functional platform reconstructs neuro-vascularization network for critical-sized bone defect regeneration10.1016/j.cej.2023.143015 ↗
30. Multilayered inorganic microparticles for tunable dual growth factor delivery10.1002/adfm.201302859 ↗
31. Nanostructured mineral coatings stabilize proteins for therapeutic delivery
32. KERS-inspired nanostructured mineral coatings boost IFN-γ mRNA therapeutic index for antitumor immunotherapy
33. Ab initio modelling of protein-biomaterial interactions: influence of amino acid polar side chains on adsorption at hydroxyapatite surfaces10.1098/rsta.2011.0236 ↗
34. Defect induced charge redistribution and enhanced adsorption of lysozyme on hydroxyapatite for efficient antibacterial activity10.1021/acs.langmuir.1c01666 ↗
35. Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier10.1016/j.msec.2018.11.042 ↗
36. Surface charge and the effect of excess calcium ions on the hydroxyapatite surface10.1016/j.biomaterials.2005.04.060 ↗
37. Determination of hydroxyproline in tissues and the evaluation of the collagen content of the tissues10.1134/S106193480701011X ↗
38. Salvianolic acid A attenuates arsenic-induced ferroptosis and kidney injury via HIF-2 α/DUOX1/GPX4 and iron homeostasis10.1016/j.scitotenv.2023.168073 ↗
39. Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy10.1016/j.biopha.2023.114382 ↗